General description
Dasatinib is a BCR-ABL tyrosine kinase inhibitor used in treatment protocols for various leukaemias.
INN
Dasatinib
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2017
(TRS
1006)
for
Chronic myeloid leukaemia, not elsewhere classified
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
- Oral > Solid: 20 mg tablet; 50 mg tablet; 70 mg tablet; 80 mg tablet; 100 mg tablet; 140 mg tablet